India to unveil ambitious pharma policy transforming industry dynamics

22 November 2023

Signalling a strategic shift towards research, artificial intelligence (AI), blockchain, and patent laws, the Indian government has released a draft of the National Pharmaceutical Policy, inviting crucial inputs from industry stakeholders.

The policy aims to create a supportive framework for the pharmaceutical industry to thrive. With a vision for India to maintain global leadership in pharmaceuticals, the policy aims to significantly boost local manufacturing, elevate economic competitiveness, and promote self-reliance.

Acknowledging the potential of digital technologies, including data analytics, the policy aims to revolutionize pharmaceutical innovation. AI, machine learning, and blockchain are identified as key enablers to enhance drug safety, supply chain management, and regulatory compliance.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK